关注
Jason Miska
Jason Miska
在 northwestern.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells
AL Chang, J Miska, DA Wainwright, M Dey, CV Rivetta, D Yu, D Kanojia, ...
Cancer research 76 (19), 5671-5682, 2016
5552016
HIF-1α is a metabolic switch between glycolytic-driven migration and oxidative phosphorylation-driven immunosuppression of Tregs in glioblastoma
J Miska, C Lee-Chang, A Rashidi, ME Muroski, AL Chang, ...
Cell Reports 27 (1), 226-237. e4, 2019
2512019
Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation
LK Billingham, JS Stoolman, K Vasan, AE Rodriguez, TA Poor, M Szibor, ...
Nature immunology 23 (5), 692-704, 2022
1482022
Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma
P Zhang, J Miska, C Lee-Chang, A Rashidi, WK Panek, S An, M Zannikou, ...
Proceedings of the National Academy of Sciences 116 (47), 23714-23723, 2019
1232019
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
J Fares, AU Ahmed, IV Ulasov, AM Sonabend, J Miska, C Lee-Chang, ...
The Lancet Oncology 22 (8), 1103-1114, 2021
1152021
Myeloid-derived suppressive cells promote B cell–mediated immunosuppression via transfer of PD-L1 in glioblastoma
C Lee-Chang, A Rashidi, J Miska, P Zhang, KC Pituch, D Hou, T Xiao, ...
Cancer immunology research 7 (12), 1928-1943, 2019
1122019
Activation of dopamine receptor 2 prompts transcriptomic and metabolic plasticity in glioblastoma
SP Caragher, JM Shireman, M Huang, J Miska, F Atashi, S Baisiwala, ...
Journal of Neuroscience 39 (11), 1982-1993, 2019
832019
Sui generis: gene therapy and delivery systems for the treatment of glioblastoma
JR Kane, J Miska, JS Young, D Kanojia, JW Kim, MS Lesniak
Neuro-oncology 17 (suppl_2), ii24-ii36, 2015
782015
Real-time immune cell interactions in target tissue during autoimmune-induced damage and graft tolerance
J Miska, MH Abdulreda, P Devarajan, JB Lui, J Suzuki, A Pileggi, ...
Journal of Experimental Medicine 211 (3), 441-456, 2014
772014
FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis
A Cordero, D Kanojia, J Miska, WK Panek, A Xiao, Y Han, N Bonamici, ...
Oncogene 38 (37), 6445-6460, 2019
722019
Adoptive transfer of IL13Rα2-specific chimeric antigen receptor T cells creates a pro-inflammatory environment in glioblastoma
KC Pituch, J Miska, G Krenciute, WK Panek, G Li, T Rodriguez-Cruz, ...
Molecular therapy 26 (4), 986-995, 2018
692018
OX40+ plasmacytoid dendritic cells in the tumor microenvironment promote antitumor immunity
K Poropatich, D Dominguez, WC Chan, J Andrade, Y Zha, B Wray, ...
The Journal of clinical investigation 130 (7), 3528-3542, 2020
672020
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
P Zhang, A Rashidi, J Zhao, C Silvers, H Wang, B Castro, A Ellingwood, ...
Nature communications 14 (1), 1610, 2023
622023
βIII-tubulin regulates breast cancer metastases to the brain
D Kanojia, RA Morshed, L Zhang, JM Miska, J Qiao, JW Kim, P Pytel, ...
Molecular cancer therapeutics 14 (5), 1152-1161, 2015
622015
Dendritic cell–based vaccines that utilize myeloid rather than plasmacytoid cells offer a superior survival advantage in malignant glioma
M Dey, AL Chang, J Miska, DA Wainwright, AU Ahmed, IV Balyasnikova, ...
The Journal of Immunology 195 (1), 367-376, 2015
612015
Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma
J Miska, A Rashidi, C Lee-Chang, P Gao, A Lopez-Rosas, P Zhang, ...
Science Advances 7 (8), eabc8929, 2021
582021
Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment
C Wu, ME Muroski, J Miska, C Lee-Chang, Y Shen, A Rashidi, P Zhang, ...
Nanomedicine: Nanotechnology, Biology and Medicine 16, 126-137, 2019
542019
Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma
C Lee-Chang, J Miska, D Hou, A Rashidi, P Zhang, RA Burga, ...
Journal of Experimental Medicine 218 (1), e20200913, 2020
482020
De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma
JM Shireman, F Atashi, G Lee, ES Ali, MR Saathoff, CH Park, S Savchuk, ...
Brain 144 (4), 1230-1246, 2021
452021
Anti-GITR therapy promotes immunity against malignant glioma in a murine model
J Miska, A Rashidi, AL Chang, ME Muroski, Y Han, L Zhang, MS Lesniak
Cancer Immunology, Immunotherapy 65, 1555-1567, 2016
442016
系统目前无法执行此操作,请稍后再试。
文章 1–20